Hbk Investments L P Spectrum Pharmaceuticals Inc Transaction History

Hbk Investments L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$9.08 - $11.84 $593,323 - $773,672	-65,344 Reduced 49.06%	67,856 $725,000
Q4 2018 Feb 14, 2019	BUY	$6.39 - $16.99 $368,703 - $980,322	57,700 Added 76.42%	133,200 $1.17 Million
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $885,207 - $1.33 Million	53,584 Added 244.5%	75,500 $1.27 Million
Q2 2018 Aug 14, 2018	SELL	$14.31 - $21.75 $731,012 - $1.11 Million	-51,084 Reduced 69.98%	21,916 $459,000
Q1 2018 May 15, 2018	BUY	$16.09 - $23.07 $849,922 - $1.22 Million	52,823 Added 261.8%	73,000 $1.18 Million
Q4 2017 Feb 14, 2018	SELL	$13.36 - $20.73 $115,203 - $178,754	-8,623 Reduced 29.94%	20,177 $382,000
Q3 2017 Nov 14, 2017	BUY	$8.75 - $14.07 $252,000 - $405,216	28,800	28,800 $405,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.